Kramer-Geli Sandra MD Santa Barbara, CA - 93105

Kramer-Geli Sandra MD is categorized under Internal Medicine Practitioners in Santa Barbara, CA and active since 2013.

Kramer-Geli Sandra MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Sandra Kramer-Geli at the company’s single location by writing to 317 West Pueblo St, Santa Barbara, California CA 93105 or by phoning (805) 681-7500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Kramer-Geli Sandra MD
Contact Person: Sandra Kramer-Geli
Address: 317 West Pueblo St, Santa Barbara, California 93105
Phone Number: (805) 681-7500
Annual Revenue (USD): $500.000 to $999.999
Founded: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Kramer-Geli Sandra MD was started in 2013 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Sandra Kramer-Geli for inquiries that concern Kramer-Geli Sandra MD by calling the company number (805) 681-7500, as your correspondence is most welcome. Additionally, the physical location of the single location of Kramer-Geli Sandra MD can be found at the coordinates 34.42989,-119.72257 as well as the street address 317 West Pueblo St in Santa Barbara, California 93105.

For its online presence, you may visit Kramer-Geli Sandra MD’s website at and engage with its social media outlets through on Twitter and on Facebook.